Park Avenue Securities’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
ATO
RG
YIH
BPC
FFM
BPCE
Park Avenue Securities's BSX Position: Q2 2026 in Review
Park Avenue Securities increased its Boston Scientific (BSX) stake by 292% in Q2 2026, buying an estimated $3.6M and bringing the position to 88,935 shares worth $3.8M. The position accounts for 0.02% of the portfolio, ranked #457.
Park Avenue Securities first reported a position in BSX in Q4 2019 and has held it in 20 quarters since. The position peaked at $5.33M in Q2 2025. 338 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Park Avenue Securities held 88,935 shares of Boston Scientific worth $3.8M as of Q2 2026.
- Park Avenue Securities bought 66,269 Boston Scientific shares in Q2 2026, an estimated $3.6M.
- Boston Scientific made up 0.02% of Park Avenue Securities's portfolio in Q2 2026, its #457 holding.
- Park Avenue Securities first reported a position in Boston Scientific in Q4 2019 and has held it in 20 quarters since.
- Park Avenue Securities's Boston Scientific position peaked at $5.33M in Q2 2025.
- 338 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.